At Celgene, we have taken a holistic and long-term approach to assessing the value of our innovative medicines and ensuring that this value is also reflected in the manner in which we price our medicines. It is our goal to clearly define how Celgene measures the value of our medicines. We seek to develop therapies that are capable of improving patient outcomes and their quality of life, with benefits that can extend to the surrounding health system, the economy and even the perpetuation of innovation within our society.

As such, we focus on the following four pillars of value in innovation:

  1. Value to patients
  2. Value to the health system
  3. Value to the economy and society
  4. Value to future innovation

To learn more about how we approach the concept of value, click here to view the 2018 Value and Innovation Framework Report.